Abiopharma

🔍 Britt Christopher R (Director)

Company: Chime Financial, Inc. (CHYM)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 200,000 shares of Class A Common Stock (Direct)
  Date: 2026-08-06 | Code: C | equity_swap_involved: 0 | shares_owned_after: 200,000.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 100,000 shares of Class A Common Stock at $28.2402 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F2, F1
• Sold 100,000 shares of Class A Common Stock at $30.1399 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F1
• Acquired 83,000 shares of Class A Common Stock (Direct)
  Date: 2026-08-07 | Code: C | equity_swap_involved: 0 | shares_owned_after: 83,000.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 83,000 shares of Class A Common Stock at $30.3988 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F4, F1
• Acquired 49,843 shares of Class A Common Stock (Direct)
  Date: 2026-08-07 | Code: C | equity_swap_involved: 0 | shares_owned_after: 117,000.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 67,157 shares of Class A Common Stock at $30.5389 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 49,843.00 | transaction_form_type: 4 | Footnotes: F2, F6, F5
• Sold 49,843 shares of Class A Common Stock at $30.6252 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F7, F5
• Acquired 150,000 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: C | equity_swap_involved: 0 | shares_owned_after: 150,000.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 150,000 shares of Class A Common Stock at $30.1566 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F8, F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-06 | Code: H | shares_owned_after: 258,959.00 | Footnotes: F9
• Sold 200,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-06 | Code: C | equity_swap_involved: 0 | shares_owned_after: 83,000.00 | transaction_form_type: 4 | Footnotes: F10, F10, F10, F1
• Sold 83,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-07 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F10, F10, F10, F1
• Sold 49,843 shares of Class B Common Stock (Derivative)
  Date: 2026-08-07 | Code: C | equity_swap_involved: 0 | shares_owned_after: 14,593,721.00 | transaction_form_type: 4 | Footnotes: F10, F10, F10, F5
• Sold 150,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-10 | Code: C | equity_swap_involved: 0 | shares_owned_after: 14,443,721.00 | transaction_form_type: 4 | Footnotes: F10, F10, F10, F5
• Holds 466,599 shares of Class B Common Stock (Derivative)
  Date: 2026-08-06 | Code: H | shares_owned_after: 466,599.00 | Footnotes: F10, F10, F10, F11
• Holds 500,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-06 | Code: H | shares_owned_after: 500,000.00 | Footnotes: F10, F10, F10, F12
• Holds 500,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-06 | Code: H | shares_owned_after: 500,000.00 | Footnotes: F10, F10, F10, F13
• Holds 466,599 shares of Class B Common Stock (Derivative)
  Date: 2026-08-06 | Code: H | shares_owned_after: 466,599.00 | Footnotes: F10, F10, F10, F14

Footnotes:

• F1: The shares are held by the Reporting Person's spouse.
• F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2025.
• F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.32 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
• F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.51 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
• F5: The shares are held by the Britt Living Trust, for which the Reporting Person serves as trustee.
• F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.51 to $30.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
• F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.56 to $30.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
• F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.36 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
• F9: Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
• F10: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
• F11: The shares are held by the Tiger GRAT, for which William Gheen III serves as trustee.
• F12: The shares are held by held by the Aloha Trust, for which William Gheen III serves as trustee.
• F13: The shares are held by the Tiger Trust, for which William Gheen III serves as trustee.
• F14: The shares are held by the Aloha GRAT, for which William Gheen III serves as trustee.